Civic Intelligence

The Pharmaceutical Compliance

990EZ • Fiscal year 2013 • EIN 46-3312253

Jan 01, 2013 to Dec 31, 2013

Myrtle Beach, SC
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

47th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2013 filings • 501(c)6 • <$500k nonprofits • Source year 2013

Liabilities / Revenue

48th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2013 filings • 501(c)6 • <$500k nonprofits • Source year 2013

Net Margin

90th percentile

27%

Higher net margin than 90% of similar nonprofits.

2013 filings • 501(c)6 • <$500k nonprofits • Source year 2013

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2013

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Assets

$8,043

No earlier filing loaded for comparison.

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$29,681

No earlier filing loaded for comparison.

Expenses

$21,638

No earlier filing loaded for comparison.

Net Income

$8,043

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0Assets 2013: $8,043Liabilities 2013: $02013Assets 2014: $66,028Liabilities 2014: $0Net Assets 2014: $66,0282014Assets 2015: $105,578Liabilities 2015: $0Net Assets 2015: $105,5782015Assets 2016: $127,727Liabilities 2016: $0Net Assets 2016: $127,7272016Assets 2017: $125,329Liabilities 2017: $0Net Assets 2017: $125,3292017Assets 2018: $73,091Liabilities 2018: $0Net Assets 2018: $73,0912018Assets 2019: $139,418Liabilities 2019: $0Net Assets 2019: $139,4182019Assets 2020: $222,133Liabilities 2020: $0Net Assets 2020: $222,1332020Assets 2021: $299,517Liabilities 2021: $0Net Assets 2021: $299,5172021Assets 2022: $495,147Liabilities 2022: $0Net Assets 2022: $495,1472022Assets 2023: $549,347Liabilities 2023: $0Net Assets 2023: $549,3472023Assets 2024: $586,962Liabilities 2024: $0Net Assets 2024: $586,9622024

Highlighted filing

2013

Assets$8,043
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$600K$400K$200K$0-$200KRevenue 2013: $29,681Expenses 2013: $21,638Net Income 2013: $8,0432013Revenue 2014: $250,400Expenses 2014: $192,415Net Income 2014: $57,9852014Revenue 2015: $195,400Expenses 2015: $155,850Net Income 2015: $39,5502015Revenue 2016: $245,350Expenses 2016: $223,201Net Income 2016: $22,1492016Revenue 2017: $258,425Expenses 2017: $260,823Net Income 2017: -$2,3982017Revenue 2018: $226,260Expenses 2018: $278,498Net Income 2018: -$52,2382018Revenue 2019: $303,704Expenses 2019: $237,378Net Income 2019: $66,3262019Revenue 2020: $287,315Expenses 2020: $204,600Net Income 2020: $82,7152020Revenue 2021: $306,305Expenses 2021: $228,921Net Income 2021: $77,3842021Revenue 2022: $400,254Expenses 2022: $204,624Net Income 2022: $195,6302022Revenue 2023: $439,308Expenses 2023: $385,108Net Income 2023: $54,2002023Revenue 2024: $472,237Expenses 2024: $434,622Net Income 2024: $37,6152024

Highlighted filing

2013

Revenue$29,681
Expenses$21,638
Net Income$8,043
Filing Detail Status

This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview

Mission

The mission of the pharmaceutical compliance forum, inc. Is to be the leading forum in the pharmaceutical industry for promoting excellence in the compliance profession and advancing effective compliance programs through solutions-oriented collaboration and innovative best practice sharing.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings